Kyra A Gelderman Selected Research

Gluten-Free Diet

6/2014	Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.
4/2013	Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease.
1/2013	Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyra A Gelderman Research Topics

Disease

7	Arthritis (Polyarthritis) 02/2011 - 08/2006
6	Neoplasms (Cancer) 04/2006 - 01/2002
4	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 10/2007
4	Infections 12/2021 - 01/2018
4	Inflammation (Inflammations) 01/2020 - 09/2006
3	Rheumatoid Arthritis 01/2023 - 09/2006
3	Colorectal Neoplasms (Colorectal Cancer) 04/2006 - 01/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 01/2023
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2023 - 01/2020
2	Lung Diseases (Lung Disease) 01/2020 - 01/2018
2	Tuberculosis (Tuberculoses) 01/2020 - 01/2018
2	Celiac Disease (Celiac Sprue) 06/2014 - 04/2013
2	Neoplasm Metastasis (Metastasis) 06/2004 - 05/2004
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2023
1	Brain Injuries (Brain Injury) 12/2023
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2023
1	COVID-19 01/2023
1	Glomerulonephritis 01/2023
1	Systemic Vasculitis 01/2023
1	Guillain-Barre Syndrome 01/2023
1	Myasthenia Gravis 01/2023
1	Thrombotic Thrombocytopenic Purpura 01/2023
1	Pemphigus (Pemphigus Vulgaris) 01/2023
1	Dermatomyositis (Dermatopolymyositis) 01/2020
1	Atypical Hemolytic Uremic Syndrome 01/2018
1	Paraproteinemias (Monoclonal Gammopathy) 01/2018
1	Crohn Disease (Crohn's Disease) 06/2014
1	Ulcerative Colitis 06/2014
1	Atrophy 01/2013
1	Experimental Arthritis 10/2007
1	Necrosis 09/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2004
1	Neoplasm Micrometastasis 05/2004
1	Carcinoma (Carcinomatosis) 04/2002

Drug/Important Bio-Agent (IBA)

12	Complement System Proteins (Complement)IBA 12/2023 - 01/2002
7	AntigensIBA 12/2021 - 04/2002
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2002
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011 - 08/2006
5	AntibodiesIBA 12/2023 - 04/2006
4	AutoantibodiesIBA 12/2023 - 07/2009
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	neutrophil cytosolic factor 1IBA 07/2009 - 08/2006
3	Collagen Type II (Type II Collagen)IBA 07/2009 - 08/2007
3	Epithelial Cell Adhesion MoleculeIBA 04/2006 - 01/2002
3	Monoclonal AntibodiesIBA 12/2005 - 04/2002
2	EpitopesIBA 12/2023 - 08/2007
2	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 01/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2007 - 08/2007
2	beta-GlucansIBA 04/2006 - 05/2004
2	Bispecific AntibodiesIBA 06/2004 - 04/2002
1	Fc Receptors (Fc Receptor)IBA 12/2023
1	Complement C5 (Complement 5)IBA 12/2023
1	eculizumab FDA Link 12/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	C-Reactive ProteinIBA 12/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2020
1	N 30IBA 01/2020
1	Immunoglobulin A (IgA)IBA 06/2014
1	Oxidoreductases (Dehydrogenase)IBA 10/2010
1	AutoantigensIBA 07/2009
1	CollagenIBA 10/2007
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 08/2007
1	Oxygen (Dioxygen)IBA 08/2007
1	Histocompatibility Antigens Class IIIBA 08/2007
1	Methotrexate (Mexate)FDA LinkGeneric 09/2006
1	PhytolIBA 09/2006
1	Glutathione (Reduced Glutathione)IBA 08/2006
1	Sulfhydryl Compounds (Thiols)IBA 08/2006
1	Complement C3b (C3bi)IBA 04/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2006
1	cobra venom factorIBA 06/2004
1	G250 monoclonal antibodyIBA 05/2004
1	SuspensionsIBA 04/2002
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 04/2002

Therapy/Procedure

5	Immunotherapy 04/2006 - 01/2002
3	Gluten-Free Diet 06/2014 - 01/2013
2	Therapeutics 01/2018 - 09/2006
1	Drug Therapy (Chemotherapy) 05/2004